Relapsed Mantle Cell Lymphoma: Current Management, Recent Progress, and Future Directions

The increasing number of approved therapies for relapsed mantle cell lymphoma (MCL) provides patients effective treatment options, with increasing complexity in prioritization and sequencing of these therapies. Chemo-immunotherapy remains widely used as frontline MCL treatment with multiple targeted...

Descripción completa

Detalles Bibliográficos
Autores principales: Bond, David A, Martin, Peter, Maddocks, Kami J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000187/
https://www.ncbi.nlm.nih.gov/pubmed/33799484
http://dx.doi.org/10.3390/jcm10061207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000187/
https://www.ncbi.nlm.nih.gov/pubmed/33799484
http://dx.doi.org/10.3390/jcm10061207

Ejemplares similares